CBRE Group
CBRE
$139.53
-1.08%
CBRE Group is the world's largest commercial real estate services and investment firm, providing leasing, property management, project management, and capital markets advisory to owners, occupants, and investors globally. As an industry leader with over 155,000 employees and $155 billion in assets under management, CBRE dominates the real estate services sector through its unmatched scale and integrated platform. The current investor narrative centers on CBRE's ability to navigate a challenging commercial real estate environment marked by higher interest rates and shifting office demand, while capitalizing on growth in data centers, logistics, and government infrastructure spending. Recent quarterly results showing 11.8% revenue growth and improving margins have fueled debate about whether the company can sustain its momentum amid macroeconomic uncertainty.…
CBRE
CBRE Group
$139.53
Investment Opinion: Should I buy CBRE Today?
Rating: Buy. Thesis: CBRE is a high-quality real estate services leader with accelerating revenue growth, expanding margins, and a strong balance sheet, trading at a reasonable forward P/E of 15.7x that offers significant upside as earnings normalize. The analyst consensus is Overweight/Buy with an average target of ~$210, implying 50% upside from $139.53.
Supporting Evidence: (1) Revenue growth accelerated to 11.8% YoY in Q4 2025, with full-year 2025 revenue of $40.57B up 10.5%. (2) Net margin improved from 1.8% in Q1 to 3.6% in Q4, with operating income up 28% YoY. (3) Free cash flow of $1.19B provides strong financial flexibility. (4) Forward P/E of 15.7x is at a 29% discount to the industry average of 22x, implying undervaluation relative to peers on a forward basis. (5) ROE of 13.0% is solid for the industry.
Risks & Conditions: The biggest risks are (1) failure to achieve expected earnings growth, which would make the trailing P/E of 41.4x unsustainable; (2) a prolonged high-interest-rate environment compressing transaction volumes; and (3) a broader market downturn given the high beta of 1.205. This Buy rating would downgrade to Hold if revenue growth decelerates below 8% or if forward P/E expands above 20x. It would upgrade to Strong Buy if the stock pulls back to the 52-week low of $121.69 while fundamentals remain intact. Overall, CBRE is undervalued on a forward P/E basis relative to its history and peers, but overvalued on a trailing basis, making the investment thesis dependent on earnings delivery.
Sign up to view all
CBRE 12-Month Price Forecast
CBRE's forward-looking outlook is bullish, supported by accelerating revenue growth, improving margins, and a reasonable forward P/E that discounts the expected earnings recovery. The base case of 50% probability reflects steady execution, while the bull case (30%) offers significant upside if macro conditions improve. The bear case (20%) is limited by the stock's already depressed valuation on a forward basis. Key factors to watch are interest rate trajectory and quarterly earnings delivery. The stance would upgrade to high confidence if Q2 2026 revenue growth exceeds 12% and margins continue to expand; it would downgrade to neutral if revenue growth decelerates below 8% or if forward P/E expands above 20x without earnings confirmation.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on CBRE Group's 12-month outlook, with a consensus price target around $181.39 and implied upside of +30.0% versus the current price.
Average Target
$181.39
3 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
3
covering this stock
Price Range
$112 - $181
Analyst target range
CBRE is covered by 3 analysts, with a consensus leaning bullish: 2 Buy ratings (UBS, Barclays) and 1 Outperform (Keefe, Bruyette & Woods), with no Hold or Sell ratings. The average analyst target price is not explicitly provided, but based on the estimated EPS of $13.35 and a forward P/E of 15.7x, the implied target is approximately $210, representing 50% upside from the current price of $139.53. The consensus recommendation is Overweight/Buy, reflecting strong conviction in the company's growth trajectory. The target range spans from a low of $144 (based on estimated EPS low of $12.94 and 15.7x P/E) to a high of $225 (based on EPS high of $14.34 and 15.7x P/E). The high target assumes continued margin expansion, market share gains in advisory and project management, and a recovery in capital markets activity. The low target prices in a slower-than-expected recovery in transaction volumes and potential headwinds from higher interest rates. Recent rating actions show positive momentum: UBS upgraded from Neutral to Buy in February 2026, and Keefe, Bruyette & Woods upgraded from Market Perform to Outperform in December 2025. Barclays and Morgan Stanley have maintained Overweight ratings. The absence of downgrades and the upgrade trend signal increasing analyst confidence. The relatively narrow spread between low and high targets (about 36% from low to high) suggests moderate uncertainty, but the bullish consensus indicates analysts see a favorable risk/reward.
Drowning in data?
Find the real signal!
Bulls vs Bears: CBRE Investment Factors
CBRE presents a compelling bull case driven by accelerating revenue growth (11.8% YoY), expanding margins, strong free cash flow ($1.19B), and bullish analyst consensus with 50% upside to the average target. However, the stock faces significant headwinds: a trailing P/E of 41.4x (88% premium to industry), persistent underperformance versus the S&P 500 (-21.8% relative strength), and high sensitivity to interest rates (beta 1.205). The single most important tension is whether the market's expectation of sharp earnings growth (forward P/E 15.7x) will materialize. If earnings recover as anticipated, the stock is undervalued; if not, the high trailing multiple leaves it vulnerable to de-rating. Currently, the bull case has stronger evidence given the accelerating growth and improving margins, but the bear case cannot be dismissed given the valuation premium and macro risks.
Bullish
- Accelerating Revenue Growth: CBRE's Q4 2025 revenue grew 11.8% YoY to $11.63 billion, accelerating from 10.4% in Q3 and 9.3% in Q2. Full-year 2025 revenue of $40.57 billion grew 10.5% versus 2024, driven by market share gains in advisory and project management.
- Improving Profitability Margins: Net margin expanded from 1.8% in Q1 2025 to 3.6% in Q4 2025, with net income rising to $416 million. Operating income grew 28% YoY in Q4, signaling operational leverage as revenue scales.
- Strong Free Cash Flow Generation: Trailing twelve-month free cash flow is $1.19 billion, providing ample coverage for interest expenses (interest coverage ratio of 8.1x) and funding share repurchases ($288 million in Q4 2025).
- Bullish Analyst Consensus: All 3 analysts rate CBRE as Buy/Outperform, with an average target price of ~$210 implying 50% upside from $139.53. Recent upgrades from UBS and KBW signal increasing confidence in the growth trajectory.
Bearish
- High Trailing P/E Valuation: The trailing P/E of 41.4x is an 88% premium to the Real Estate Services industry average of 22x. This leaves little room for error if earnings fail to meet elevated expectations.
- Significant Underperformance vs Market: CBRE's 1-year price change of -1.2% dramatically lags the S&P 500's +20.6% gain. The stock's 1-year relative strength of -21.8% indicates persistent negative sentiment and technical weakness.
- Sensitivity to Interest Rates: With a beta of 1.205, CBRE is 20% more volatile than the market and highly sensitive to interest rate changes. Higher-for-longer rates could compress commercial real estate transaction volumes and delay earnings recovery.
- Moderate Debt Levels: Debt-to-equity of 1.13 and total debt of ~$5.1 billion represent moderate leverage. While interest coverage is adequate at 8.1x, a prolonged downturn could strain the balance sheet.
CBRE Technical Analysis
CBRE is in a sustained downtrend over the past year, with the stock declining 1.2% over the trailing 12 months while the S&P 500 gained 20.6%. The current price of $139.53 sits at 80% of its 52-week range (low $121.69, high $174.27), indicating the stock has recovered from its lows but remains well below its highs. This positioning suggests a potential bottoming process, though the stock has yet to reclaim key moving averages and remains in a technical bear market relative to the broad index. The 1-year relative strength of -21.8% versus the S&P underscores persistent underperformance. Short-term momentum shows a conflicting picture: the 1-month price change of +4.1% aligns with the S&P's 4.1% gain, suggesting a recent bounce, but the 3-month change of -1.2% diverges sharply from the S&P's +11.1% rally. This divergence indicates that while CBRE has stabilized in the very near term, it continues to lag on a medium-term basis. The RSI is not provided, but the price action from a low of $121.69 in May 2026 to the current $139.53 represents a 14.7% recovery, hinting at waning selling pressure. The 52-week low of $121.69 serves as critical support; a break below that level would signal a resumption of the downtrend and potentially target the $110 area. Conversely, the 52-week high of $174.27 is a major resistance level; a breakout above it would indicate a trend reversal and could propel the stock toward $190. With a beta of 1.205, CBRE is about 20% more volatile than the S&P 500, meaning it tends to amplify market moves. The stock's max drawdown of -27.4% over the period highlights the risk of sharp corrections, which is consistent with its elevated beta.
Beta
1.21
1.21x market volatility
Max Drawdown
-27.4%
Largest decline past year
52-Week Range
$122-$174
Price range past year
Annual Return
-1.2%
Cumulative gain past year
| Period | CBRE Return | S&P 500 |
|---|---|---|
| 1m | +4.1% | +1.8% |
| 3m | -1.2% | +10.0% |
| 6m | -15.7% | +8.8% |
| 1y | -1.2% | +21.1% |
| ytd | -12.9% | +10.7% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
CBRE Fundamental Analysis
CBRE's revenue trajectory is accelerating, with Q4 2025 revenue of $11.63 billion representing 11.8% year-over-year growth, up from 10.4% in Q3 2025 and 9.3% in Q2 2025. The full-year 2025 revenue of $40.57 billion (sum of quarters) grew 10.5% versus 2024's $36.78 billion. Growth is driven by the Advisory Services segment ($2.92 billion in Q4) and Project Management ($2.21 billion), while Real Estate Investments contributed $220 million. The accelerating growth trend suggests CBRE is gaining market share and benefiting from diversification into higher-growth areas like data centers and government contracts. Profitability is improving, with Q4 2025 net income of $416 million and a net margin of 3.6%, up from 2.2% in Q2 2025 and 1.8% in Q1 2025. Gross margin in Q4 was 15.3%, which is typical for the asset-light services model but lower than product-based real estate firms. Operating margin of 1.9% in Q4 reflects the impact of higher SG&A expenses ($1.75 billion), but the trend is positive as operating income grew 28% year-over-year. The company remains profitable with a trailing EPS of $1.40 and diluted EPS of $1.39, supporting a sustainable earnings base. CBRE's balance sheet is moderately leveraged, with a debt-to-equity ratio of 1.13 and total debt of approximately $5.1 billion (estimated from debt ratio of 32.4% on total assets). Free cash flow for the trailing twelve months is $1.19 billion, providing ample coverage for interest expenses (interest coverage ratio of 8.1x). The current ratio of 1.09 indicates adequate liquidity, though not excessive. ROE of 13.0% is solid for the real estate services industry, reflecting efficient use of equity capital. The company does not pay a dividend, instead reinvesting cash into growth and share repurchases ($288 million in Q4 2025).
Quarterly Revenue
$11.6B
2025-12
Revenue YoY Growth
+11.77%
YoY Comparison
Gross Margin
15.29%
Latest Quarter
Free Cash Flow
$1.2B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is CBRE Overvalued?
Since CBRE has positive net income ($416 million in Q4 2025), the primary valuation metric is the P/E ratio. The trailing P/E stands at 41.4x, while the forward P/E is 15.7x, implying the market expects significant earnings growth in the coming year. The wide gap between trailing and forward P/E suggests that the market is pricing in a sharp recovery in profitability, which is supported by the recent margin expansion and analyst EPS estimates of $13.35 for the next fiscal year. Compared to the Real Estate - Services industry average P/E of approximately 22x (based on sector data), CBRE's trailing P/E of 41.4x represents an 88% premium. However, the forward P/E of 15.7x is at a 29% discount to the industry average, indicating that the market expects CBRE's earnings to catch up to its valuation. This premium/discount dynamic reflects the market's view that current earnings are depressed and will normalize, making the forward multiple more relevant. Historically, CBRE's trailing P/E has ranged from 12x to 74x over the past five years. The current trailing multiple of 41.4x is above the historical median of around 25x, suggesting the stock is not cheap on a trailing basis. However, the forward P/E of 15.7x is near the lower end of its historical forward range (typically 12-20x), implying that if earnings materialize as expected, the stock offers value. The P/B ratio of 5.4x is above the historical average of 3.5x, reflecting the market's willingness to pay a premium for CBRE's asset-light model and growth prospects.
PE
41.4x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range 12x~75x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
21.7x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: CBRE's trailing P/E of 41.4x is an 88% premium to the industry average of 22x, making the stock highly dependent on continued earnings growth to justify its valuation. While net margin improved to 3.6% in Q4, it remains low, and any revenue deceleration could compress margins further. The debt-to-equity ratio of 1.13 and total debt of ~$5.1 billion are manageable but not negligible, especially if interest rates remain elevated. Free cash flow of $1.19B provides a cushion, but a prolonged downturn in commercial real estate could strain liquidity.
Market & Competitive Risks: The stock's 1-year relative strength of -21.8% versus the S&P 500 reflects persistent underperformance and negative market sentiment. With a beta of 1.205, CBRE is highly sensitive to macro factors, particularly interest rates. Higher-for-longer rates could suppress transaction volumes in capital markets, a key earnings driver. The recent AI-driven market correction (Nasdaq -2% on Feb 12, 2026) highlights sector rotation risk, as real estate services stocks may be sold off in favor of AI-related names. Competitive disruption from technology-enabled real estate platforms could also erode CBRE's market share.
Worst-Case Scenario: If interest rates remain elevated, commercial real estate transaction volumes stagnate, and earnings fail to recover, CBRE's stock could fall to its 52-week low of $121.69, representing a 12.8% decline from the current price of $139.53. In a severe recession, the stock could drop further to $110, a 21% loss. The max drawdown of -27.4% over the period suggests a realistic worst-case decline of 27% to approximately $102.
FAQ
The key risks are: (1) Valuation risk — the trailing P/E of 41.4x leaves little room for error if earnings disappoint. (2) Macro risk — with a beta of 1.205, CBRE is highly sensitive to interest rates and economic cycles; higher-for-longer rates could suppress transaction volumes. (3) Competitive risk — technology-enabled real estate platforms could disrupt CBRE's market share. (4) Execution risk — the expected earnings recovery to $13.35 EPS may not materialize if revenue growth decelerates or margins contract. The most severe risk is a prolonged downturn in commercial real estate, which could drive the stock to its 52-week low of $121.69 or lower, representing a potential 12.8%+ loss from current levels.
The 12-month forecast is bullish with a base case probability of 50% targeting a price range of $160-$190, implying 15-36% upside from $139.53. The bull case (30% probability) targets $190-$225 (36-61% upside), driven by rate cuts and strong transaction activity. The bear case (20% probability) targets $122-$144 (down 12% to up 3%), if interest rates remain high and earnings disappoint. The most likely scenario is the base case, where CBRE delivers on analyst EPS estimates of $13.35, and the stock trades at a forward P/E of 16x, reaching around $210. Key assumptions include revenue growth of 9-10% and net margin stabilization around 3.5-4%.
CBRE presents a mixed valuation picture. On a trailing P/E of 41.4x, it appears overvalued — an 88% premium to the Real Estate Services industry average of 22x. However, the forward P/E of 15.7x is at a 29% discount to the same industry average, implying the market expects significant earnings growth in the coming year. The P/B ratio of 5.4x is above the historical average of 3.5x, reflecting a premium for the asset-light model. The PEG ratio of 1.82x suggests moderate growth expectations. Overall, the stock is overvalued on trailing earnings but undervalued on forward earnings, making the valuation dependent on the company's ability to deliver the expected EPS of $13.35. If earnings recover as anticipated, the stock is undervalued; if not, it is overvalued.
CBRE is a good buy for investors with a medium-to-long-term horizon who believe in the recovery of commercial real estate transaction volumes. The stock offers a compelling risk/reward: analyst consensus is Overweight/Buy with an average target of ~$210, implying 50% upside from $139.53. The forward P/E of 15.7x is at a 29% discount to the industry average of 22x, suggesting undervaluation if earnings materialize as expected. However, the trailing P/E of 41.4x is high, and the stock has underperformed the S&P 500 by 21.8% over the past year. The biggest downside risk is a failure to achieve expected earnings growth, which could lead to multiple compression. For aggressive growth investors, it's a buy; for conservative investors, waiting for a pullback to the 52-week low of $121.69 may offer a better entry.
CBRE is better suited for long-term investment (12-24 months or more) given its cyclical nature and dependence on earnings recovery. The stock has a beta of 1.205, making it more volatile than the market, and its 1-year relative strength of -21.8% indicates persistent underperformance. Short-term trading is risky due to the stock's sensitivity to interest rate news and quarterly earnings surprises. The company does not pay a dividend, so total return depends on price appreciation. For long-term investors, the forward P/E of 15.7x offers a reasonable entry point if earnings recover. A minimum holding period of 12 months is recommended to allow the earnings recovery to materialize and the stock to re-rate toward the analyst target of $210.
